A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

Clinical trial NCT03636347 · COMPLETED

Trial details

NCT number: NCT03636347
Sponsor: Mereo BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency Emphysema COPD

Start date: 2018-10-29
Primary completion: 2022-03-02
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.